From: Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Slope (β) parameter for | β-Estimate (95% CI) | Standard Error | Wald Chi-Square | P-Value | Odds Ratio | 95% Confidence Limits | |
---|---|---|---|---|---|---|---|
Northeast Region | Reference | ||||||
Midwest Region | −0.14 (−0.28, 0.00) | 0.0721 | 3.684 | 0.055 | 0.871 | 0.756 | 1.003 |
South Region | − 0.07 (− 0.17, 0.04) | 0.0547 | 1.4505 | 0.228 | 0.936 | 0.841 | 1.042 |
West Region | −0.03 (− 0.16, 0.10) | 0.0678 | 0.2778 | 0.598 | 0.965 | 0.845 | 1.102 |
Gender – Female | Reference | ||||||
Gender – Male | −0.04 (−0.16, 0.07) | 0.058 | 0.5577 | 0.455 | 0.958 | 0.855 | 1.073 |
Primary Care | Reference | ||||||
Regular Specialty | 0.01 (−0.19, 0.22) | 0.1059 | 0.0038 | 0.951 | 1.007 | 0.818 | 1.239 |
Infectious Disease* | −0.01 (−0.18, 0.16) | 0.0854 | 0.021 | 0.885 | 0.988 | 0.835 | 1.168 |
Gastroenterologists & Hepatologists | 0.17 (0.04, 0.29) | 0.0623 | 6.7374 | 0.009 | 1.176 | 1.04 | 1.328 |
Median Income | 0.01 (−0.01, 0.03) | 8.60E-07 | 1.8362 | 0.175 | 1 | 1 | 1 |